Akèy › Anplwayè › Novartis Pharmaceuticals Corporation › Senior Principal Biostatistician
Senior Principal Biostatistician nan Novartis Pharmaceuticals Corporation: Salè H-1B
23 aplikasyon kondisyon travay pou tit travay Senior Principal Biostatistician nan Novartis Pharmaceuticals Corporation. Salè baz medyàn ofri $136,219; mwatye mitan $112,965–$142,542.
Demann (LCA)23
Salè medyan ofri$136,219
Mwatye salè yo$112,965–$142,542
10yèm–90yèm pousantaj$100,010–$151,411
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 9 | $126,027 |
| FY2024 | 9 | $136,219 |
| FY2025 | 1 | $142,771 |
| FY2026 | 4 | $120,412 |
Aplikasyon
| Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|
| $112,965 Nivo II | East Hanover, NJ | May 5, 2026 | Oct 1, 2026 | Certifye |
| $112,965 Nivo II | East Hanover, NJ | Apr 9, 2026 | Oct 1, 2026 | Certifye |
| $144,373 Nivo III | East Hanover, NJ | Apr 7, 2026 | Oct 1, 2026 | Certifye |
| $127,858 Nivo IV | Cambridge, MA | Nov 11, 2025 | Mar 28, 2026 | Certifye |
| $142,771 Nivo III | East Hanover, NJ | Mar 19, 2025 | Sep 15, 2025 | Certifye |
| $142,771 Nivo III | East Hanover, NJ | Jul 12, 2024 | Sep 1, 2024 | Certifye |
| $136,219 Nivo III | East Hanover, NJ | Jun 13, 2024 | Dec 13, 2024 | Certifye |
| $136,219 Nivo III | East Hanover, NJ | Apr 9, 2024 | Oct 1, 2024 | Certifye |
| $136,219 Nivo III | East Hanover, NJ | Apr 4, 2024 | Aug 9, 2024 | Certifye |
| $136,219 Nivo III | East Hanover, NJ | Mar 21, 2024 | Sep 20, 2024 | Certifye |
| $167,814 Nivo IV | East Hanover, NJ | Mar 21, 2024 | Sep 19, 2024 | Certifye |
| $136,219 Nivo III | East Hanover, NJ | Mar 8, 2024 | Sep 5, 2024 | Certifye |
| $104,603 Nivo II | East Hanover, NJ | Dec 1, 2023 | Dec 11, 2023 | Certifye |
| $104,603 Nivo II | East Hanover, NJ | Oct 11, 2023 | Dec 4, 2023 | Certifye |
| $136,219 Nivo III | East Hanover, NJ | Sep 8, 2023 | Feb 23, 2024 | Certifye |
| $153,171 Nivo IV | East Hanover, NJ | May 17, 2023 | Oct 1, 2023 | Certifye |
| $98,862 Nivo II | East Hanover, NJ | May 16, 2023 | Oct 1, 2023 | Certifye |
| $126,027 Nivo III | East Hanover, NJ | Apr 3, 2023 | Oct 1, 2023 | Certifye |
| $98,862 Nivo II | East Hanover, NJ | Mar 20, 2023 | Sep 18, 2023 | Certifye |
| $153,171 Nivo IV | East Hanover, NJ | Mar 16, 2023 | Sep 15, 2023 | Certifye |
| $142,314 E-3 · Nivo III | East Hanover, NJ | Nov 18, 2022 | May 10, 2023 | Certifye |
| $98,862 Nivo II | East Hanover, NJ | Oct 21, 2022 | Mar 13, 2023 | Certifye |
| $119,496 Nivo III | Cambridge, MA | Oct 11, 2022 | Jan 2, 2023 | Certifye |
Lòt travay nan Novartis Pharmaceuticals Corporation
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).